H.Res. 95 · 114th Congress
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.
- Stage
- In committee
- Sponsor
- Juan Vargas
- Introduced
- 2015-02-05
- Latest action
- 2015-02-06 · Referred to the Subcommittee on Health.
Summary
Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed.